<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The evaluation of the rare patient who presents with oral and genital <z:e sem="disease" ids="C0038363" disease_type="Disease or Syndrome" abbrv="">aphthae</z:e> or almost constant, multiple (greater than 3) <z:e sem="disease" ids="C0038363" disease_type="Disease or Syndrome" abbrv="">oral aphthae</z:e>, but no systemic signs or symptoms (i.e., complex <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e>), is difficult because no laboratory test is available to exclude <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>Six patients with complex <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> were evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, patients with simple <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e>, those with seronegative <z:hpo ids='HP_0001369'>arthritis</z:hpo>, and <z:mpath ids='MPATH_458'>normal</z:mpath> controls were assessed for circulating immune complexes (CIC) by in vitro and in vivo assays and for neutrophil migration by subagarose methods, since these tests have given significant results in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome </plain></SENT>
<SENT sid="3" pm="."><plain>Patient 1, with complex <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e>, had Raji cell evidence for CIC (51.2 mg aggregated human gamma globulin Eq/ml), C1q, and C3 in dermal blood vessels 4 hours post intradermal <z:chebi fb="11" ids="18295">histamine</z:chebi> injection and had a <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e>-like <z:hpo ids='HP_0002633'>vasculitis</z:hpo> 24 hours post <z:chebi fb="11" ids="18295">histamine</z:chebi> injection </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, her serum enhanced the migration of patient neutrophils (3.6 +/- 0.6 to 4.6 +/- 0.5; N = 6, p less than or equal to 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> other test and control patients had negative or <z:mpath ids='MPATH_458'>normal</z:mpath> CIC and neutrophil migration determinations </plain></SENT>
<SENT sid="6" pm="."><plain>Sixteen-month clinical follow-up has confirmed that Patient 1, but not Patients 2 to 6, has developed overt manifestations of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome </plain></SENT>
</text></document>